Form 8-K - Current report:
SEC Accession No. 0001654954-25-002886
Filing Date
2025-03-17
Accepted
2025-03-17 16:17:45
Documents
17
Period of Report
2025-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K drma_8k.htm   iXBRL 8-K 28814
2 PRESS RELEASE drma_ex991.htm EX-99.1 53556
8 drma_ex991img3.jpg GRAPHIC 5152
  Complete submission text file 0001654954-25-002886.txt   241518

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA drma-20250317.xsd EX-101.SCH 6311
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20250317_lab.xml EX-101.LAB 16902
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20250317_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20250317_pre.xml EX-101.PRE 12342
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20250317_def.xml EX-101.DEF 4203
19 EXTRACTED XBRL INSTANCE DOCUMENT drma_8k_htm.xml XML 5823
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 25744698
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)